在喘患者的呼吸道上皮质中观察到升高的PLAUR,阻塞改善了屏障完整性
Michael A Portelli1, Sangita Bhaker1, Vincent Pang2
1Centre for Respiratory Research, NIHR Respiratory Biomedical Research Centre, School of Medicine, Biodiscovery Institute, University Park, University of Nottingham, Nottingham, UK.
Clinical and translational allergy
|October 25, 2023
概括
在喘患者中,泌尿酸酶等离子体激活受体 (uPAR) 的升高与呼吸道上皮屏障的削弱相关. 阻止UPAR功能可以改善屏障完整性,这表明UPAR是喘治疗的治疗点.
科学领域:
- 呼吸系统医学 呼吸系统医学
- 细胞生物学 细胞生物学
- 免疫学 免疫学 免疫学
背景情况:
- 泌尿酸酶等离子体激活剂受体 (uPAR) 表达在喘患者的呼吸道上皮质中增加.
- 尤帕在喘发病的具体作用及其作为治疗点的潜力尚未完全理解.
研究的目的:
- 研究喘患者的人类支气管上皮细胞 (HBEC) 中的UPAR表达.
- 为了确定 uPAR 和上皮屏障功能之间的关系.
- 探索不同PAR异型的功能影响.
主要方法:
- 来自喘患者的HBEC和在空气液体接口 (ALI) 的量化UPAR水平.
- 评估了使用体电阻和电池阻抗传感器的屏障特性,包括PUPAR阻断抗体的影响.
- 利用转录学分析了表达过度的UPAR异型 (muPAR,scuPAR,ssuPAR) 的功能影响.
主要成果:
- 喘患者的HBECs表现出升高的UPAR表达,表明细胞内在变化.
- 在2D和ALI培养物中,可溶性UPAR水平与上皮屏障完整性呈反相关性.
- 阻断UPAR-整合素相互作用导致皮质屏障形成的改善.
- 过度表达UPAR异型导致了最小的转录基因变化.
结论:
- 这项研究澄清了喘,UPAR和上皮屏障功能障碍之间的联系.
- 循环UPAR的升高有助于表皮屏障受损,这是喘的一个特征.
- uPAR代表了一种潜在的治疗点,用于改善喘中的呼吸道屏障功能.
相关概念视频
Antiasthma Drugs: Leukotriene Modifiers
324
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
324
Asthma-II: Pathophysiology and Classification
2.7K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.7K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
312
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
312
Breathing
59.5K
The process of breathing, inhaling and exhaling, involves the coordinated movement of the chest wall, the lungs, and the muscles that move them. Two muscle groups with important roles in breathing are the diaphragm, located directly below the lungs, and the intercostal muscles, which lie between the ribs. When the diaphragm contracts, it moves downward, increasing the volume of the thoracic cavity and creating more room for the lungs to expand. When the intercostal muscles contract, the ribs...
59.5K
Asthma: Pathogenesis and Management
421
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
421
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.8K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.8K


